Frecuencia de Síntomas de Depresión en Pacientes Adolescentes con Epilepsia, Limitaciones

Los resultados de este estudio solo son aplicables únicamente a los grupos de adolescentes estudiados por lo cual no podemos generalizar los datos a una mayor población.

A pesar de ello los datos son tan contundentes que es recomendable ampliar este tipo de estudios a otras instituciones y otras poblaciones para tener un contexto más real de la depresión y la epilepsia en nuestra ciudad y de ser posible en nuestro país.

Lo ideal sería realizar un estudio multicentrico que amplié el tamaño de muestra para poder analizar la asociación real de otras variables con los síntomas de depresión que permitan caracterizar mejor los grupos de riesgo.

No se analizaron datos sociales ya que hacían parte de otro proyecto asociado a este que se desarrollo previamente por la Dra. Ana María Shapiro, Psiquiatra Infantil [123].

Consideraciones

Este estudio nos permitió obtener resultados importantes para las dos instituciones, que dada su complejidad deben atender casos más complejos y con mayores comorbilidades.

Es necesario desarrollar un protocolo para diagnóstico precoz de esta comorbilidad y de ser posible complementar el análisis con la búsqueda de otras entidades psiquiátricas concomitantes con la epilepsia que sean susceptibles de tratamiento para mejorar la calidad de vida de los pacientes.

A largo plazo se requiere un seguimiento de todos los casos con o sin depresión para ver su
evolución, la respuesta al tratamiento iniciado y su pronóstico.

El diagnóstico precoz es importante pero es también necesario conocer las diferentes opciones de tratamiento, sus indicaciones y posibles complicaciones [30, 124-130].

Referencias bibliográficas

1. Austin JK, MacLeod J, Dunn DW, Shen J, Perkins SM. Measuring stigma in children with epilepsy and their parents: instrument development and testing. Epilepsy & Behavior 5 (2004) 472 – 482.
2. Boro A, Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy & Behavior 4 (2003) S2 – S12.
3. Cabaleiro AP, Fernandez G, Saenz MP. Depresión y subjetividad. Universidad Nacional del Mar de Plata. Facultad de Psicología. 06/12/00.
4. Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol 2005; 4: 171 – 178.
5. Stafstrom CE, Havlena J. Seizure drawings: insight into the self-image in children witn epilepsy. Epilepsy & Behavior 4 (2003) 43 – 56.
6. Boylan LS, Devinsky O, Barry JJ, Ketter TA. Psychiatric uses of antiepileptic treatments. Epilepsy & Behavior 3 (2002) S54 – S59.
7. Castrén E. Is mood chemistry? Nature Reviews Volume 6 March 2005 241 – 246.
8. Celada P, Puig V, Amargós M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004; 29 (4): 252 – 265.
9. Cramer JA, Hammer AE, Kustra RP. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy & Behavior 5 (2004) 702 – 707.
10. Critchley HD. The human cortex responds to an interoceptive challenge. PNAS/ April 27, 2004/Vol 101/Nº 17/6333 – 6334.
11. Damasio AR. Emotion in the perspective of an integrated nervous system. Brain Research Reviews 26 (1998) 83 – 86.
12. Kanner AM. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Currents, Vol 6, N° 5 ( Sep – Oct) 2006 pp 141 – 146.
13. Lai CH, Trimble MR. Stress and Epilepsy. J Epilepsy 1997; 10: 177 – 186.
14. Rodenburg R, Meijer AM, Dekovic M, Aldenkamp AP. Family factors and psychopathology in children with epilepsy: A literature review. Epilepsy & Behavior 6 (2005) 488 – 503.
15. Thompson PJ, Upton D. The impact of chronic epilepsy on the family. Seizure 1992; 1: 43 – 48.
16. Leonard B. Estres, citoquinas y depresión. Simposio internacional de la asociación mundial de psiquiatría. Agosto 13 – 15, 2003.
17. Malhi GS, Parker GB, Greenwood J. Structural and functional models of depression: from sub-types to substrates. Acta Psychiatr Scand: 2005: 111: 94 – 105.
18. Morkeberg F, Vedel L, Pert T. On the increased risk of developing late-onset epilepsy for patients with major affective disorder. Journal of Affective Disorder 76 (2003) 39 – 48.
19. Mortazavi F, Ericson M, Story D, Hulce VD, Dunbar GL. Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats. Epilepsy & Behavior 7 (2005) 629 – 638.
20. Mulas F, Hernández S, Morant A. Alteraciones neuropsicológicas en los niños epilépticos. Rev Neurol Clin 2001; 2 (1): 29 – 41.
21. Soyuer F, Erdogan F, Senol V, Arman F. The relationship between fatigue and depression, and event-related potentials in epileptics. Epilepsy & Behavior 8 (2006) 581 – 587.
22. Thapar A, Roland M, Harold G. Do depression symptoms predict seizure frecuency-or vice cersa? Journal of Psychosomatic Research 59 (2005) 269 – 274.
23. Turner K, Piazzini A, Franza A, Fumarola C, Chifari R, Marconi AM, Canevini MP, Canger F. Postpartum depression in women with epilepsy versus women without epilepsy. Epilepsy & Behavior 9 (2006) 293 – 297.
24. Giovagnoli AR, Meneses RF, Martins da Silva A. The contribution of spirituality to quality of life in focal epilepsy. Epilepsy & Behavior 9 (2006) 133 – 139
25. Goldstein LH, Holland L, Soteriou H, Mellers JDC. Illness representations, coping styles and mood in adults with epilepsy. Epilepsy Research 67 (2005) 1 – 11.
26. Harden CL. Sexuality in women with epilepsy. Epilepsy & Behavior 7 (2005) S2 – S6.
27. Hoshi Y, Chen SJ. Regional cerebral blood flow changes associated with emotions in children. Pediatr Neurol 2002; 27: 275 – 281.
28. Jacobs BL. Serotonin, motor activity and depression – related disorders. American Scientist, Volume 82, 1994 September – October.
29. Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy & Behavior 4 (2003) S14 – S24.
30. Kalogjera-Sackellares D, Sackellares JCh. Improvement in depression associated with partial epilepsy in patients treated with lamotrigine. Epilepsy & Behavior 3 (2002) 510 – 516.
31. Kanner AM, Barry JJ. The impact of mood disorders in neurological diseases: should neurologists be concerned? Epilepsy & Behavior 4 (2003) S3 – S13.
32. Kanner A. Do epilepsy and psychiatric disorders share common pathogenic mechanisms? A look of depression and epilepsy. Clinical neuroscience research 4 (2004) 31 – 37.
33. Kanner A. Is major depression a neurologic disorder with psychiatric symptoms? Epilepsy & Behavior 5 (2004) 636 – 644.
34. Nieto K, Mantilla C. Psiquiatría y epilepsia en Epilepsia: Aspectos clínicos y Psicosociales de Medina M, C. Editorial Médica Panamericana, 2.004: 388 – 392, 397 – 402.
35. Nubukpo P, Preux PM, Houinato D, Radji A, Grunitzky EK, Avodè G, Clément JP. Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) I. Anxiety and depression measured using Goldberg`s scale. Epilepsy & Behavior 5 (2004) 722 – 727.
36. Pedroso EA, Barioni PC. A psychosocial view of anxiety and depression in epilepsy. Epilepsy & Behavior 8 (2006) 232 – 238.
37. Snead K, Ackerson J, Bailey K, Schmitt MM, Madan- Swain A, Martin RC. Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents. Epilepsy & Behavior 5 (2004) 547 – 556.
38. López-Gómez M, Ramirez-Bermudez J, Campillo C, Sosa AL, Espinola M, Ruiz I. Primidone is associated with interictal depression in patients with epilepsy. Epilepsy & Behavior 6 (2005) 413 – 416.
39. Morrell M, Flynn K, Done S, Flaster E, Kalayjian L, Pack AM. Sexual dysfunction, sex steroid hormone abnormalities and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy & Behavior 6 (2005) 360 – 365.
40. Rösche J, Uhlmann C, Weber R, Fröscher W. The in_ uence of folate serum levels on depressive mood and mental processing in patients with epilepsy treated with enzyme – inducing anti – epileptic drugs. Acta Neuropsychiatrica 2003; 15: 63 – 67.

41. Ali S, Moriarty J, Mullatti N, David A. Psychiatric comorbidity in adult patients with hypothalamic hamartoma. Epilepsy & Behavior 9 (2006) 111 – 118.
42. Archila R. Epilepsia y trastornos del aprendizaje. Rev Neurol 2000; 31 (4): 382 – 388.
43. Austin JK, Caplan R. Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model. Epilepsia 48 (9): 1639 – 1651, 2007.
44. Bortz JJ. Neuropsychiatric and memory issues in epilepsy. Mayo Clin Proc 2003; 78: 781 -787.
45. Gutierrez AM. Epilepsia y trastornos depresivos. Acta Neurol Colomb 2005; 21: 121 – 125.
46. Hecimovic H, Goldstein JD, Sheline YI, Gilliam FG. Mechanisms of depression in epilepsy from a clinical perspective. Epilepsy and Behavior 4 (2003) S25- S30.
47. Kandel ER. Trastornos del estado del ánimo: depresión, mania y trastornos de ansiedad in Principles of neural science of Kandel ER, Schwartz JH, Jessell TM. McGraw – Hill Interamericana, 4° edición, 2001: 1209 – 1226.
48. Mensah SA, Beavis JM, Thapar AK, Kerr M. The presence and clinical implications of depression in a community population of adults with epilepsy. Epilepsy & Behavior 8 (2006) 213 – 219.
49. Seethalakshmi R, Krishnamoorthy ES. Depression in epilepsy: phenomenology, diagnosis and management. Epileptic Disord 2007; 9 (1): 1 – 10.
50. Harden CL. The co – morbidity of depression and epilepsy: epidemiology, etiology and treatment. Neurology Vol 59 N° 6 September 24 2002.
51. Kanner A, Balabonov A. Depression and epilepsy: How closely related are they? Neurology Vol 58 Number 8 April 23 2002.
52. Kanner AM. Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment. Epilepsy & Behavior 3 (2002) S7 – S13.
53. Kanner AM. Depression in epilepsy: Prevalence, clinical semiology, pathogenic mechanism, and treatment. Biol Psychiatry 2003; 54: 388 – 398.
54. Kanner AM. Depression in epilepsy: a frequently neglected multifaceted disorder. Epilepsy & Behavior 4 (2003) S11 – S19.
55. Kanner AM. Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms? Lancet Neurology Vol 5 February 2006.
56. Mayor LC, Davila J, Quijano CA. Depresión y epilepsia. Acta Neurol Colomb 2006; 22: 278 – 282.
57. Alwash RH, Hussein MJ, Matloub FF. Symptoms of anxiety and depression among adolescents with seizures in Irbid, Northern Jordan. Seizure 2000; 9: 412 – 416.
58. Barry JJ, Jones JE. What is effective treatment of depression in people with epilepsy ? Epilepsy & Behavior 6 (2005) 520 – 528.
59. Fatoye F, Mosaku KS, Komolafe M, Adewuya AO. Interictal anxiety and depression symptoms in Nigerians with epilepsy: A controlled study. Epilepsy & Behavior 9 (2006) 312 – 316.
60. Hughes J, Devinsky O, Feldmann E, Brom_ eld E: Premonitory symptoms in epilepsy. Seizure 1993; 2: 201 – 203.
61. Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy & Behavior 4 (2003) S31 – S38.
62. Kanner A, Soto A, Gross – Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology Vol 62 Number 5 March 9 2004.
63. Krishnamoorthy ES, Trimble MR, Sander JWAS, Kanner AM. Forced normalization at the interface between epilepsy and psychiatry. Epilepsy & Behavior 5 (2002) 303 – 308.
64. Mazza M, Mazza S. Depression and suicide in epilepsy: fact or artifact? Journal of the Neurological Science xx (2007) xxx – xxx.
65. Artigas J. Manifestaciones pasicológicas de la epilepsia en la infancia. Rev Neurol 1999; 28 (Supl 2): S 135 – 141.
66. Austin JK, Dunn DW, Johnson CS, Perkins SM. Behavioral issues involving children and adolescents with epilepsy and the impact on their families: recent research dates. Epilepsy & Behavior 5 (2004) S33 – S41.
67. Baker GA, Spector S, McGrath Y, Soteriou H. Impact of epilepsy in adolescence: a UK controlled study. Epilepsy & Behavior 6 (2005) 556 – 562.
68. Bechara A, Damasio H, Damasio AR. Emotion, decision making and the orbitofrontal cortex. Cerebral Cortex Mar 2000; 10: 295 – 307.
69. Bewley J, Murphy PN, Mallows J, Baker GA. Does alexithymia differentiate between patients with nonepileptic seizures, patients with epilepsy, and non patient controls? Epilepsy & Behavior 7 (2005) 430 – 437.
70. Cramer JA, Brandenburg N, Xu X. Differentiating anxiety and depression symptoms in patients with partial epilepsy. Epilepsy & Behavior 6 (2005) 563 – 569.
71. DiIorio C, Osborne P, Letz R, Henry TR, Schomer DL, Yeager K, for the Project EASE Study Group. Behavioral, social, and affective factors associated with self-ef_ cacy for self-management among people with epilepsy. Epilepsy & Behavior 9 (2006) 1587 – 163.
72. Dunn DW, Austin JK. Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy. Epilepsy & Behavior 5 (2004) S10 – S17.
73. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet 2006: 367: 153 – 67.
74. Hankin BJ. Adolescent depression: Description, causes and interventions. Epilepsy & Behavior 8 (2006) 102 – 114.
75. Hardan A, Birmaher B, Williamson DE, Dahl RE, Ambrosini P, Rabinovich H, Neal R. Prolactin secretion in depressed children. Biol Psychiatry 1999; 46: 506 – 511.
76. Baki O, Erdogan A, Kantarci O, Akisik G, Kayaalp L, Yalainkaya C. Anxiety and depression in children with epilepsy and their mothers. Epilepsy & Behavior 5 (2004) 958 – 964.
77. Lagges AM, Dunn D. Depression in children and adolescents. Neurol Clin N Am 21 (2003) 953 – 960.
78. Baxendale S, Thompson P, Duncan JS. Epilepsy & depression: the effects of comorbidity on hippocampal volume – A pilot study. Seizure (2005) 14, 435 – 438.
79. Campbell S, Marriott M, Nahmias C, MacQueen G. Lower hipocampal volume in patients suffering from depression: a meta – analysis. Am J Psychiatry 2004; 161: 598 – 607.
80. Devinsky O. The myth of silent cortex and the morbidity of epileptogenic tissue: implications for temporal lobectomy. Epilepsy & Behavior 7 (2005) 383 – 389.
81. Dulay MF, Schefft BK, Fargo JD, Privitera MD, Yeh H. Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy. Epilepsy & Behavior 5 (2004) 522 – 531.
82. Getz K, Hermann B, Seidenberg M, Bell B, Dow Ch, Jones J, Woodard A, Rufecki P, Shet R, O’Leory D, Magnotta V. Negative symptoms in temporal lobe epilepsy. Am J Psychiatry 2002; 644 – 651.
83. Hasler G, Bonwetsch R, Giovacchini G, Toczek MT, Bagic A. 5 – HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 2007 Dic 1; 62 (11): 1258 – 1264.
84. Heimer L, Van Hoesen GW. The limbic lobe and its output channels: Implications for emotional functions and adaptive behavior. Neuroscience and Biobehavioral Reviews 30 (2006) 126 – 147.
85. Helmstaedter Ch, Sonntag-Dillender M, Hoppe Ch, Elger ChE. Depressed mood and memory impairment in temporal epilepsy as a function of focus lateralization and localization. Epilepsy & Behavior 5 (2004) 696 –701.
86. Kühn K-U, Quednow BB, Thiel M, Falkai P, Maier W, Elger ChE. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy & Behavior 4 (2003) 674 – 679.
87. Meldolesi GN, Picardi A, Quarato PP, Grammaldo LG, Esposito V, Mascia A, Sparano A, Morosini P, Di Gennaro G. Factors associated with generic and diseasespeci _ c quality of life in temporal lobe epilepsy. Epilepsy Research 69 (2006) 135 – 146.
88. Monaco F, Cavanna A, Magli E, Barbagli D, Collimedaglia L, Cantello R, Mula M. Obsessionality obsessivecompulsive disorder, and temporal lobe epilepsy. Epilepsy & Behavior 7 (2005) 491 – 496.
89. Mula M, Sander JW, Trimble MR. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study with levetiracetam. Seizure (2006) 15, 405 – 408.
90. Reynders HJ, Broks P, Dickson JM, Lee CE, Turpin G. Investigation of social and emotion information processing in temporal lobe epilepsy with ictal fear. Epilepsy & Behavior 7 (2005) 419 – 429.
91. Reuber M, Andersen B, Elger ChE, Helmstaedter Ch. Depression and anxiety before and after temporal lobe surgery. Seizure 2004; 13: 129 – 135.
92. Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. PNAS/October 23, 2001/ Vol 98/Nº 22.
93. Willard KS, Licht BG, Gilmore RL, Licht MH, Sackellares JCh, Eisenschenk SJ, Bowers D, Hyson L, Kirsch L. Affect in patients with epilepsy undergoing video/ EEG monitoring: Retrospective versus momentary assessment and temporal relationship to seizures. Epilepsy & Behavior 8 (2006) 625 – 634.
94. Barry JJ. The recognition and management of mood disorders as a comorbidity of epilepsy. Epilepsia, 44 (Suppl 4): 30 – 40, 2003.
95. Dunn DW, Austin JK. Behavioral issues in pediatric epilepsy. Neurology Vol 53(5) Supplement 2 September 22 1999.
96. Grabowska-Grzyb A, Jedrzejczak J, Naganska E, Fiszer U. Risk factors for depression in patients with epilepsy. Epilepsy & Behavior 8 (2006) 411 – 417.
97. Jagadheesan K, Garg AK, Nizamie H. Risk factors and outcome of mood disorders in epilepsy: a case-control study. Seizure 2003; 12: 121-125.
98. Thome-Souza S, Kuczynski E, Assumpçäo F Jr, Rzezak P, Fuentes D, Fiore L, Valente KD. Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy? Epilepsy & Behavior 5 (2004) 988 – 994.
99. Davanzo P, Kerwin L, Nikore V, Esparza C, Forness S. Spanish translation and reliability testing of the child depression inventory. Child Psychiatry and Human Development, Vol 35 (1), 2004.
100. Vinaccia S, Gaviria AM, Atehortúa LF, Martínez PH, Trujillo C et al. Prevalencia de depresión en niños escolarizados entre 8 y 12 años del oriente antioqueño a partir del “child depression inventory” – CDI. Diversitas – Perspectivas en Psicología Vol 2, N° 1, 2006.
101. Plioplys S. Depression in children and adolescents with epilepsy. Epilepsy & Behavior 4 (2003) S39 – S45.
102. Post RM. Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanism? Epilepsy Research 50 (2002) 203 – 219.
103. Rios JR, Hernandez M. Prevalencia de depresión en pacientes con epilepsia y su calidad de vida. Rev Sanid Milit Mex 2005; 59 (5) Sep – Oct: 311 – 317.
104. Beghi E, Roncolato M, Visoná G. Depression and altered quality of life in women with epilepsy of childbearing age. Epilepsia 45 (1): 64 – 70, 2004.
105. Cramer JA, Blum D, Fanning K, Reed M. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy & Behavior 5 (2004) 337 – 342.
106. Gonzalez AG. Deterioro neuropsicológico en niños con epilepsia. Investigación en salud Vol VIII N° 1 Abril 2006.
107. Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy & Behavior 5 (2004) 976 – 980.
108. Attarian H, Vahle V, Carter J, Hykes E, Gilliam F. Relationship between depression and intractability of seizures. Epilepsy & Behavior 4 (2003) 298 – 301.
109. Grif_ th NM, Sza_ arsky JP, Sza_ arsky M, Kent GP, Schefft BK, Howe SR, Privitera MD. Measuring depressive symptoms among treatment-resistant seizure disorder patients:POMS Depression scale as an alternative to the BDI-II. Epilepsy & Behavior 7 (2005) 266 – 272.
110. Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs. Seizure (2006) 15, 504 – 508.
111. Chacon V, Muñoz CX, Rivas JC, Miranda CA. Estudio descriptivo de la prevalencia de depresión en pacientes con epilepsia que consultan al Hospital Psiquiátrico Universitario del Valle (HPUV) y la Liga contra la Epilepsia (LCE) en Cali, Colombia. Revista Colombiana de Psiquiatría, Vol XXXVI/N° 1/2007.
112. Beyenburg S, Mitchell AJ, Schmidt D, Elger ChE, Reuber M. Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management. Epilepsy & Behavior 7 (2005) 161 – 171.
113. Buelow JM, McNelis A. Should every child with epilepsy undergo a neuropsychological evaluation? Epilepsy & Behavior 3 (2002) 210 – 213.
114. Krishnamoorthy ES, Trimble MR, Blumer D. The classification of neuropsychiatric disorders in epilepsy: A proposal by the ILAE commission on psychobiology of epilepsy. Epilepsy & Behavior 10 (2007) 349 – 353.
115. Pellock JM. Understanding co – morbidities affecting children with epilepsy. Neurology Vol 62 Number 5 March 9 2004.
116. Pellock JM. Defining the problem: psychiatric and behavioral comorbidity in children and adolescents with epilepsy. Epilepsy & Behavior 5 (2004) S3 – S9.
117. Stagno SJ. Psychiatric aspects of epilepsy in The treatment of epilepsy. Principles and practice of Wyllie E. Lippincott Williams & Wilkins, 3° edición, 2001: 1227 – 1242.
118. Swinkels WAM, Duijsens IJ, Spinhoven Ph. Personality disorder traits in patients with epilepsy. Seizure 2003; 12: 587 – 594.
119. Alanis-Guevara I, Peña E, Corona T, López-Ayala T, López-Mesa E, López-Gómez M. Sleep disturbances, socioeconomic status, and seizure control as main predictors of quality of life in epilepsy. Epilepsy & Behavior 7 (2005) 481 – 485.
120. Sza_ arski M, Meckler JM, Privitera MD, Sza_ arski JP. Quality of life in medication-resistant epilepsy: The effects of patient`s age, age at seizure onset, and disease duration. Epilepsy & Behavior 8 (2006) 547 – 551.
121. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. The Lancet Vol 5 May 2006.
122. Guerrero E, Guerrero S. Epilepsia y depresión: un enfoque desde la atención primaria. Revista Chilena de Epilepsia Año 7, N° 1, Junio 2006.
123. Shapiro AM, Ñungo N, Alvarez A, Izquierdo A, Vasquez R. Tratamiento de la depresión en adolescentes con epilepsia atendidos en la Fundación Hospital de la Misericordia en el periodo comprendido entre febrero y octubre de 2007. Tesis de Postgrado, U Bosque, 2008.
124. Gilliam F, Kanner AM. Treatment of depressive disorders in epilepsy patients. Epilepsy & Behavior 3 (2002) S2 – S9.
125. Hallböök T, Lundgren J, Stjernqvist K, Blennow G, Strömblad LG, Rosèn I. Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure (2005) 14, 504 – 513.
126. Husum H, Bolwig TG, Sanchez C, Mathè AA, Hansen SL. Levetiracetam prevents changes in levels of brainderived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties. Epilepsy & Behavior 5 (2004) 204 – 215.
127. Kanner AM. Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes. Epilepsy & Behavior 6 (2005) 303 – 311.
128. Krishnamoorthy ES. Treatment of depression in patients with epilepsy: problems, pitfalls, and some solutions. Epilepsy & Behavior 4 (2003) S46 – S54.
129. Marangell LB, Martinez JM, Niazi ShK. Vagus nerve stimulation as a potential option for treatment-resistant depression. Clinical Neuroscience Research 4 (2004) 89-94.
130. Newman T. A black – box warning for antidepressants in children. N Engl J Med 351: 16 Oct 14 2004: 1595 – 1598.